Clear Harbor Asset Management’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Clear Harbor Asset Management’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-2,700	Closed	-$43K	–	273
2018 Q4	$43K	Hold	2,700	–	–	0.01%	232
2018 Q3	$59K	Sell	2,700 -1,100	-29%	-$28.3K	0.01%	247
2018 Q2	$86K	Buy	3,800 +1,000	+36%	+$23.7K	0.02%	241
2018 Q1	$81K	Buy	2,800 +300	+12%	+$8.78K	0.02%	225
2017 Q4	$70K	Hold	2,500	–	–	0.01%	239
2017 Q3	$91K	Sell	2,500 -7,500	-75%	-$232K	0.02%	238
2017 Q2	$289K	Buy	+10,000	New	+$78.7K	0.06%	199

Other funds holding AVEO

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

EWM

Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Clear Harbor Asset Management's AVEO Position: Q1 2019 in Review

Clear Harbor Asset Management sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2019, closing a stake of 2,700 shares — an estimated $43K sold.

Clear Harbor Asset Management first reported a position in AVEO in Q2 2017 and held it in 7 quarters. The position peaked at $289K in Q2 2017. 83 funds tracked by Wall St. Rank hold AVEO as of Q1 2019.

Clear Harbor Asset Management reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2019 after selling out during the quarter.
Clear Harbor Asset Management sold 2,700 AVEO Pharmaceuticals, Inc. shares in Q1 2019, an estimated $43K.
Clear Harbor Asset Management first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2017 and held it in 7 quarters.
Clear Harbor Asset Management's AVEO Pharmaceuticals, Inc. position peaked at $289K in Q2 2017.
83 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2019.

Based on Clear Harbor Asset Management's 13F filing for Q1 2019, filed 19 Apr 2019.